Abstract OT2-05-01: BRCAsearch: A population based prospective study on screening for BRCA1 and BRCA2 germline mutations in patients with newly diagnosed breast cancer treated in southern Sweden
MP Nilsson(Lund University), Niklas Loman(Lund University), Barbro Silfverberg, Katharina Henriksson(Lund University), Åke Borg, Anders Kvist(Lund University), Ulf Kristoffersson, Therese Törngren(Lund University)
Cited by 0
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
|Cancer Cell|2017|534